Please assess the completion status of the following clinical trial:

Trial Title: Special Drug Use Surveillance of Vonoprazan for Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~- Participants with a history of gastric or duodenal ulcer~Exclusion Criteria:~* Participants with gastric or duodenal ulcer at initiation of vonoprazan therapy~* Participants with active upper gastrointestinal haemorrhage at initiation of vonoprazan therapy~* Participants with a history of hypersensitivity to any ingredients of vonoprazan Tablets~* Participants receiving atazanavir sulfate or rilpivirine hydrochloride

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vonoprazan 10 mg (Type: None): The usual adult dosage for oral use is 10 mg of Vonoprazan administered once daily. Participants will receive interventions as part of routine medical care.

Based on this trial design, predict the completion outcome and termination type (if applicable).